Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 28Endometrial Neoplasms 9Vaginal Neoplasms 5Ovarian Neoplasms 5Vulvar Neoplasms 3Fallopian Tube Neoplasms 3Esophageal Neoplasms 3Endometrial Clear Cell Adenocarcinoma 3Uterine Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Neoplasms 2Melanoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Peritoneal Neoplasms 1Pelvic Inflammatory Disease 1Patient Compliance 1Neoplasm Metastasis 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma, Myxoid 1Hyperthermia 1Head and Neck Neoplasms 1HIV Infections 1Endometriosis 1Endometrial Adenocarcinoma 1Diarrhea 1

Interventions

Radiation 1Octreotide 1Loperamide 1Fecal Microbiota Transplantation 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diarrhea × Radiation × Gynecologic × Clear all
NCT00033605 2016-07-13

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Alliance for Clinical Trials in Oncology

Phase 3 Completed
130 enrolled
GastrointestinalGenitourinaryGynecologicSarcoma

Uterine Cervical Neoplasms, Diarrhea, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡